| Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma (NCT00001337) | National Cancer Institute (NCI) | 1993-05-08 |
| Agriculture Health Study (NCT00352924) | National Cancer Institute (NCI) | 1993-04-30 |
| In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients (NCT00342485) | National Cancer Institute (NCI) | 1993-04-12 |
| In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients (NCT00001336) | National Cancer Institute (NCI) | 1993-04-01 |
| New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma (NCT00001335) | National Cancer Institute (NCI) | 1993-04-01 |
| Phase I Study of Intrathecal Topotecan (NCT00001333) | National Cancer Institute (NCI) | 1993-02-01 |
| Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis (NCT00001332) | National Cancer Institute (NCI) | 1992-12-01 |
| A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 (NCT00001302) | National Cancer Institute (NCI) | 1992-09-01 |
| Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors (NCT00001301) | National Cancer Institute (NCI) | 1992-08-01 |
| A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma (NCT00001300) | National Cancer Institute (NCI) | 1992-06-01 |
| Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China (NCT00340405) | National Cancer Institute (NCI) | 1992-04-30 |
| A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction (NCT00001298) | National Cancer Institute (NCI) | 1992-03-01 |
| Study of Scaling Disorders and Other Inherited Skin Diseases (NCT00001292) | National Cancer Institute (NCI) | 1992-02-01 |
| A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma (NCT00001296) | National Cancer Institute (NCI) | 1992-02-01 |
| Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease (NCT00001295) | National Cancer Institute (NCI) | 1992-01-29 |
| Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens (NCT00001294) | National Cancer Institute (NCI) | 1992-01-01 |
| A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients (NCT00001272) | National Cancer Institute (NCI) | 1991-09-01 |
| Women's Health Trial: Feasibility Study in Minority Populations (NCT00000481) | National Cancer Institute (NCI) | 1991-09-01 |
| A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma (NCT00001271) | National Cancer Institute (NCI) | 1991-07-01 |
| Polyp Prevention Trial (NCT00339625) | National Cancer Institute (NCI) | 1991-06-19 |
| Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma (NCT00001270) | National Cancer Institute (NCI) | 1991-06-01 |
| Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer (NCT00001269) | National Cancer Institute (NCI) | 1991-05-01 |
| Interleukin-2 in Treating Patients With Metastatic Kidney Cancer (NCT00018941) | National Cancer Institute (NCI) | 1991-04-01 |
| Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders (NCT00001238) | National Cancer Institute (NCI) | 1990-12-05 |
| A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine (NCT00001267) | National Cancer Institute (NCI) | 1990-10-01 |
| A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma (NCT00001266) | National Cancer Institute (NCI) | 1990-10-01 |
| Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial (NCT00001250) | National Cancer Institute (NCI) | 1989-12-01 |
| Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac (NCT00001249) | National Cancer Institute (NCI) | 1989-12-01 |
| Phase I Study of Intrathecal Mafosfamide (NCT00001251) | National Cancer Institute (NCI) | 1989-11-01 |
| Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer (NCT00001239) | National Cancer Institute (NCI) | 1989-07-01 |
| Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas (NCT00001237) | National Cancer Institute (NCI) | 1989-03-01 |
| Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer (NCT00394511) | National Cancer Institute (NCI) | 1988-08-01 |
| Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study (NCT00001217) | National Cancer Institute (NCI) | 1987-05-01 |
| Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines (NCT00001210) | National Cancer Institute (NCI) | 1986-11-01 |
| A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors (NCT00001209) | National Cancer Institute (NCI) | 1986-10-01 |
| Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer (NCT00001163) | National Cancer Institute (NCI) | 1985-04-02 |
| A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer (NCT00001193) | National Cancer Institute (NCI) | 1984-11-01 |
| The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities (NCT00001188) | National Cancer Institute (NCI) | 1983-12-01 |
| The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors (NCT00001189) | National Cancer Institute (NCI) | 1983-12-01 |
| Psychological Benefits of a Normalized Camping Experience for Children With Cancer (NCT00001186) | National Cancer Institute (NCI) | 1983-02-15 |
| The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation (NCT01468883) | National Cancer Institute (NCI) | 1979-09-04 |
| Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers (NCT00001164) | National Cancer Institute (NCI) | 1978-07-01 |
| The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases (NCT00005660) | National Cancer Institute (NCI) | 1977-10-01 |
| Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System (NCT00001158) | National Cancer Institute (NCI) | 1977-04-01 |
| Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers (NCT00001150) | National Cancer Institute (NCI) | 1976-10-01 |
| Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer (NCT00253526) | National Cancer Institute (NCI) | |
| BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00024115) | National Cancer Institute (NCI) | |
| Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma (NCT00003801) | National Cancer Institute (NCI) | |
| Study of a Polymorphism in Patients With Prostate Cancer (NCT00900185) | National Cancer Institute (NCI) | |
| A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection (NCT00000652) | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma (NCT00019890) | National Cancer Institute (NCI) | |
| Celecoxib in Preventing Skin Cancer (NCT00025051) | National Cancer Institute (NCI) | |
| Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia (NCT00030355) | National Cancer Institute (NCI) | |